Frontiers in Oncology (Jul 2023)

Editorial: Metabolic reprogramming for acquiring therapeutic resistance in glioblastoma

Tsung-I Hsu,
Tsung-I Hsu,
Tsung-I Hsu,
Tsung-I Hsu

Affiliations

Tsung-I Hsu: Ph.D. Program in Medical Neuroscience, College of Medical Science and Technology, Taipei Medical University and National Health Research Institutes, Taipei, Taiwan
Tsung-I Hsu: International Master Program in Medical Neuroscience, College of Medical Science and Technology, Taipei Medical University, Taipei, Taiwan
Tsung-I Hsu: Taipei Medical University Research Center of Neuroscience, Taipei, Taiwan
Tsung-I Hsu: Taipei Medical University Research Center of Cancer Translational Medicine, Taipei, Taiwan

DOI: https://doi.org/10.3389/fonc.2023.1220063
Journal volume & issue: Vol. 13

Abstract

No abstracts available.

Published in Frontiers in Oncology

ISSN: 2234-943X (Online)
Publisher: Frontiers Media S.A.
Country of publisher: Switzerland
LCC subjects: Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
Website: https://www.frontiersin.org/journals/oncology/

About the journal